EGFR and lung cancer: A study confirmed that under the action of various small molecule inhibitors against KRAS-, EGFR-, or ALK-driven lung cancer, the intrinsic apoptosis pathway in mitochondria is activated, and activated GSDME mediates apoptosis (12).